NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a global data and AI company, announced that Patrick “Pat” Geraghty, a seasoned chief executive with a strong record of innovation across the healthcare industry, has been appointed to EXL’s Board of Directors as an independent director effective October 20, 2025. Geraghty will be a member of the board’s audit and nominating and governance committees.
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a global data and AI company, announced that Patrick “Pat” Geraghty, a seasoned chief executive with a strong record of innovation across the healthcare industry, has been appointed to EXL’s Board of Directors as an independent director effective October 20, 2025. Geraghty will be a member of the board’s audit and nominating and governance committees. Nasdaq:EXLS, US3020811044
